HK1252779A1 - 抗真菌的4-(4-(4-(((3r,5r)-5-((1h-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氫呋喃-3-基)甲氧基)-3-甲基苯基)哌嗪-1-基)-n-(2-羥基環己基)苯甲酰胺或其可藥用鹽 - Google Patents
抗真菌的4-(4-(4-(((3r,5r)-5-((1h-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氫呋喃-3-基)甲氧基)-3-甲基苯基)哌嗪-1-基)-n-(2-羥基環己基)苯甲酰胺或其可藥用鹽Info
- Publication number
- HK1252779A1 HK1252779A1 HK18112141.3A HK18112141A HK1252779A1 HK 1252779 A1 HK1252779 A1 HK 1252779A1 HK 18112141 A HK18112141 A HK 18112141A HK 1252779 A1 HK1252779 A1 HK 1252779A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- roxycyc
- nzam
- exyl
- piperazin
- difluorophenyl
- Prior art date
Links
- 230000000843 anti-fungal effect Effects 0.000 title 1
- 229940121375 antifungal agent Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15168637 | 2015-05-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1252779A1 true HK1252779A1 (zh) | 2019-05-31 |
Family
ID=53267232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18112141.3A HK1252779A1 (zh) | 2015-05-21 | 2018-09-20 | 抗真菌的4-(4-(4-(((3r,5r)-5-((1h-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氫呋喃-3-基)甲氧基)-3-甲基苯基)哌嗪-1-基)-n-(2-羥基環己基)苯甲酰胺或其可藥用鹽 |
Country Status (17)
Country | Link |
---|---|
US (3) | US9969720B2 (zh) |
EP (1) | EP3298006B1 (zh) |
JP (1) | JP6811727B2 (zh) |
KR (1) | KR102653821B1 (zh) |
CN (1) | CN107635988B (zh) |
AU (1) | AU2016263669B2 (zh) |
CA (1) | CA2981945C (zh) |
DK (1) | DK3298006T3 (zh) |
EA (1) | EA032454B1 (zh) |
ES (1) | ES2790723T3 (zh) |
HK (1) | HK1252779A1 (zh) |
HU (1) | HUE048843T2 (zh) |
IL (1) | IL254943B (zh) |
MX (1) | MX2017014814A (zh) |
NZ (1) | NZ735783A (zh) |
SG (1) | SG11201708007VA (zh) |
WO (1) | WO2016185225A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2017014814A (es) * | 2015-05-21 | 2018-02-15 | Pulmocide Ltd | 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-triazol-1-il)metil)-5-(2,4-difluor ofenil)tetrahidrofuran-3-il)metoxi)-3-metilfenil)piperazin-1-il)- n-(2-hidroxiciclohexil) benzamida antifungica, o una sal farmaceuticamente aceptable de la misma. |
CN109329288A (zh) * | 2018-11-09 | 2019-02-15 | 青岛农业大学 | 伏立康唑在制备用于防治植物病原菌的杀菌剂中的应用 |
US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1292472C (en) | 1985-12-03 | 1991-11-26 | Alfonsus Guilielmus Knaeps | Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
JPH0717634B2 (ja) | 1987-11-20 | 1995-03-01 | シェリング・コーポレーション | トリ‐およびテトラ‐置換‐オキセタンおよびテトラヒドロフランおよびその中間体 |
US5039676A (en) * | 1990-05-11 | 1991-08-13 | Schering Corporation | Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof |
US5714490A (en) | 1993-12-21 | 1998-02-03 | Schering Corporation | Tetrahydrofuran antifungals |
ATE204875T1 (de) * | 1993-12-21 | 2001-09-15 | Schering Corp | Fungizide tetrahydrofurane |
US5486625A (en) | 1994-07-08 | 1996-01-23 | Schering Corporation | Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents |
SK27097A3 (en) | 1995-06-02 | 1997-09-10 | Schering Corp | Tetrahydrofuran antifungals |
EP0957101A1 (en) * | 1998-05-14 | 1999-11-17 | Janssen Pharmaceutica N.V. | Water soluble azoles as broad-spectrum antifungals |
AU2002257104B2 (en) | 2001-04-03 | 2006-02-09 | Merck Sharp & Dohme Corp. | Antifungal composition with enhanced bioavailability |
EP1870405A1 (en) * | 2006-06-22 | 2007-12-26 | Bioprojet | Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands |
CN101402613B (zh) * | 2008-11-14 | 2013-07-24 | 中国人民解放军第二军医大学 | 取代酚氧烷基胺三唑醇类抗真菌化合物及其制备方法 |
CN102234267A (zh) * | 2010-04-21 | 2011-11-09 | 中国科学院上海药物研究所 | 新型三氮唑类抗真菌化合物、其药物组合物及其制备方法和用途 |
US9346791B2 (en) * | 2011-09-07 | 2016-05-24 | The Johns Hopkins University | Itraconazole analogs and use thereof |
DK3227277T3 (da) | 2014-12-05 | 2020-04-27 | Pulmocide Ltd | Antimykotisk forbindelse |
MX2017014814A (es) * | 2015-05-21 | 2018-02-15 | Pulmocide Ltd | 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-triazol-1-il)metil)-5-(2,4-difluor ofenil)tetrahidrofuran-3-il)metoxi)-3-metilfenil)piperazin-1-il)- n-(2-hidroxiciclohexil) benzamida antifungica, o una sal farmaceuticamente aceptable de la misma. |
-
2016
- 2016-05-20 MX MX2017014814A patent/MX2017014814A/es unknown
- 2016-05-20 CN CN201680028971.4A patent/CN107635988B/zh active Active
- 2016-05-20 EP EP16724958.0A patent/EP3298006B1/en active Active
- 2016-05-20 HU HUE16724958A patent/HUE048843T2/hu unknown
- 2016-05-20 SG SG11201708007VA patent/SG11201708007VA/en unknown
- 2016-05-20 CA CA2981945A patent/CA2981945C/en active Active
- 2016-05-20 DK DK16724958.0T patent/DK3298006T3/da active
- 2016-05-20 ES ES16724958T patent/ES2790723T3/es active Active
- 2016-05-20 KR KR1020177033395A patent/KR102653821B1/ko active IP Right Grant
- 2016-05-20 AU AU2016263669A patent/AU2016263669B2/en active Active
- 2016-05-20 NZ NZ735783A patent/NZ735783A/en unknown
- 2016-05-20 EA EA201792558A patent/EA032454B1/ru not_active IP Right Cessation
- 2016-05-20 JP JP2017560525A patent/JP6811727B2/ja active Active
- 2016-05-20 WO PCT/GB2016/051467 patent/WO2016185225A1/en active Application Filing
- 2016-11-09 US US15/347,402 patent/US9969720B2/en active Active
-
2017
- 2017-10-09 IL IL254943A patent/IL254943B/en active IP Right Grant
-
2018
- 2018-05-04 US US15/971,316 patent/US10280155B2/en active Active
- 2018-09-20 HK HK18112141.3A patent/HK1252779A1/zh unknown
-
2019
- 2019-03-20 US US16/359,349 patent/US10513511B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20180251453A1 (en) | 2018-09-06 |
KR20180010189A (ko) | 2018-01-30 |
EP3298006A1 (en) | 2018-03-28 |
ES2790723T3 (es) | 2020-10-29 |
BR112017020807A2 (pt) | 2018-07-03 |
JP6811727B2 (ja) | 2021-01-20 |
US9969720B2 (en) | 2018-05-15 |
US10280155B2 (en) | 2019-05-07 |
US20170114047A1 (en) | 2017-04-27 |
EP3298006B1 (en) | 2020-01-01 |
CN107635988B (zh) | 2021-06-18 |
WO2016185225A1 (en) | 2016-11-24 |
CA2981945A1 (en) | 2016-11-24 |
NZ735783A (en) | 2021-12-24 |
CN107635988A (zh) | 2018-01-26 |
EA032454B1 (ru) | 2019-05-31 |
US10513511B2 (en) | 2019-12-24 |
AU2016263669A1 (en) | 2017-10-12 |
DK3298006T3 (da) | 2020-03-30 |
AU2016263669B2 (en) | 2020-04-30 |
IL254943A0 (en) | 2017-12-31 |
US20190202813A1 (en) | 2019-07-04 |
HUE048843T2 (hu) | 2020-08-28 |
IL254943B (en) | 2021-01-31 |
CA2981945C (en) | 2023-08-29 |
MX2017014814A (es) | 2018-02-15 |
EA201792558A1 (ru) | 2018-05-31 |
KR102653821B1 (ko) | 2024-04-02 |
JP2018520104A (ja) | 2018-07-26 |
SG11201708007VA (en) | 2017-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL259118A (en) | Substituted oxadiazoles for combating phytopathogenic fungi | |
ZA201801534B (en) | New uses of 2-(2,4-dichlorophenyl)methyl-4,4-dimethyl-3-isoxazolidone as foliar herbicide | |
PL3529246T3 (pl) | Oksadiazole o działaniu grzybobójczym | |
GB201615051D0 (en) | Multi-modal medical image procesing | |
IL247833A0 (en) | 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-converted-pyridin-2-yl)-3-(1h-tetrazol-1-yl)propan-2-ols and processes for their preparation | |
IL247832A0 (en) | 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-converted-pyridin-2-yl)-3-(1h-tetrazol-1-yl)propan-2-ols and processes for their preparation | |
IL260908B (en) | Substituted 2-(het)aryl-imidazolyl-carboxyamides as pest control agents | |
HK1252779A1 (zh) | 抗真菌的4-(4-(4-(((3r,5r)-5-((1h-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氫呋喃-3-基)甲氧基)-3-甲基苯基)哌嗪-1-基)-n-(2-羥基環己基)苯甲酰胺或其可藥用鹽 | |
ZA202103457B (en) | Pesticidal compounds | |
IL275484A (en) | W/O/W microemulsions for ophthalmic administration | |
IL260403B (en) | Formulations of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide | |
ZA201807105B (en) | Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide | |
DK3395342T3 (da) | Tablet omfattende 1-(3-(2-(1-benzothiophen-5-YL)ethoxy)propyl)azetidin-3-ol eller salt deraf | |
EP3630964A4 (en) | THERAPEUTIC AGENTS FOR GLYCOGEN STORAGE DISEASE TYPE III | |
HUE060120T2 (hu) | Herbicidként aktív 4-difluormetilbenzoilamid | |
EP3426260A4 (en) | FOR THE TREATMENT OF DISEASES USEFUL C-GLYCOSIDE COMPOUNDS | |
ZA201804843B (en) | Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl) acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1h-1,2,3-triazole-4-carboxamide | |
IL271399A (en) | Methods for the preparation of heterocyclic 3,1-benzodioxole compounds | |
HUE045226T2 (hu) | Herbicid hatású N-(1,3,4-oxadiazol-2-il)arilkarboxamid-származékok | |
EP3534879A4 (en) | FOAM FOR PULMONARY DRUG ADMINISTRATION | |
IL243650A0 (en) | History of 1-(piperazine-1-yl)-2-([4,2,1]triazol-1-yl)-ethanone | |
EP3541797A4 (en) | 4 - ((6- (2- (2,4-DIFLUORPHENYL) -1,1-DIFLUOR-2-HYDROXY-3- (5-MERCAPTO-1H | |
IL265893A (en) | Crystal forms of 4-(2-((r1(2r,-2-hydroxycyclohexylamino)benzothiazol-6-yloxy)-n-methylpicolinamide | |
MA43157A (fr) | Sels de 1-(4-(2-((1-(3,4-difluorophényl)-1h-pyrazol-3-yl)méthoxy)éthyl) pipérazin-1-yl)éthanone | |
IT201900000597U1 (it) | Tavola fermapiede per ponteggi. |